Home Podcasts Endocrine Deep Dives
Endocrine Deep Dives

Endocrine Deep Dives

Gurbir Gill, MD 39 Episodes Jul 3, 2026

Endocrine Deep Dives covers advanced topics in endocrinology using AI-driven synthetic audio discussions derived from the host's study notes. Each episode breaks down complex endocrine concepts for healthcare providers and medical students. The content represents the host's personal opinions and does not constitute medical advice.

Episodes

Joy of osteoporosis coding (guide in description) Jul 3, 2026 00:39:44 This episode goes into the intricacies of osteoporosis coding.https://share.jotbird.com/soft-steady-mesa-willow
Trabecular bone score Jul 3, 2026 00:21:19 In this episode, we dive into the Trabecular Bone Score, a groundbreaking imaging tool redefining how we assess skeletal health. While traditional bone density scans only measure mineral quantity, this technology evaluates the internal microarchitecture of the lumbar spine. We explore why many patients suffer fractures despite normal density scores, and how this tool bridges diagnostic gaps for in
Basics of Medicare parts A-D Jul 2, 2026 00:43:08 This episode is my take on understanding the basics or Medicare insurance. More episodes to come.
Acromegaly Management Jul 2, 2026 00:23:54 This episode breaks down the clinical management matrix for acromegaly, providing an advanced roadmap for endocrinologists managing growth hormone hypersecretion. We review transsphenoidal surgery guidelines, post-operative remission metrics, and tailored medical management algorithms. Discover how to strategically navigate first and second generation somatostatin receptor ligands, dopamine agonis
Acromegaly Diagnosis Jul 1, 2026 00:17:35 This episode explores the clinical progression, diagnosis, and long term management of acromegaly, a rare condition driven by chronic growth hormone excess. We trace the patient journey from early subtle metabolic shifts to irreversible skeletal changes and systemic organ damage caused by prolonged diagnostic delays. The discussion breaks down the essential diagnostic protocol including insulin li
Acromegaly pathophysiology Jun 30, 2026 00:20:13 In this episode, we break down the complex pathophysiological and genetic landscape of acromegaly, looking beyond the simple diagnosis of growth hormone hypersecretion. We explore the critical cellular differences between densely and sparsely granulated somatotroph adenomas, detailing how their unique cytokeratin networks and somatostatin receptor profiles dictate treatment response. Finally, we e
MASLD and MASH Jun 29, 2026 00:25:02 This episode delivers a comprehensive clinical review of metabolic dysfunction associated steatotic liver disease (MASLD) and its progressive stage, metabolic dysfunction associated steatohepatitis (MASH). We explore the multi organ pathogenic cascade driven by insulin resistance and lipotoxicity. Listeners will gain practical insights into non invasive risk stratification using the FIB-4 index an
Thyroid eye disease Jun 28, 2026 00:22:20 In this episode, we unpack the complex mechanisms of Thyroid Eye Disease (TED). Explore the synergistic crosstalk between TSH and IGF-1 receptors on orbital fibroblasts, driving adipogenesis and fibrosis via hyaluronan accumulation. We break down the clinical activity score, staging protocols, and first-line therapies—including intravenous methylprednisolone regimens and the targeted IGF-1 recepto
Thyroid Storm Jun 27, 2026 00:38:05 This episode explores the critical transition from uncomplicated thyrotoxicosis to thyroid storm, focusing on the systemic homeostatic collapse driven by cellular hyper-responsiveness rather than absolute serum hormone concentrations. We analyze the molecular mechanisms of hyperpyrexia via mitochondrial uncoupling proteins one and three, alongside the intracellular signaling changes that cause pro
Everything about PTU Jun 26, 2026 00:42:56 This episode reviews the clinical pharmacology of propylthiouracil and its evolution in modern endocrinology practice. We examine its history from its discovery in the 1940s to its replacement by methimazole as the preferred first-line antithyroid therapy. The discussion covers the unique dual mechanism of propylthiouracil, focusing on both thyroid peroxidase inhibition and the inhibition of perip
Everything about methimazole Jun 25, 2026 00:56:33 This episode provides a comprehensive review of methimazole for clinical endocrinologists, focusing on its historical context, pharmacological profile, and practical management strategies. We examine its mechanism of action, specifically the inhibition of thyroid peroxidase to block iodine organification and coupling, alongside its distinct pharmacokinetics that allow for once-daily dosing. The di
Thyroid disorders in pregnancy Jun 24, 2026 01:06:43 This podcast episode provides an advanced clinical review of maternal thyroid dysfunction during gestation and the postpartum period tailored for practicing endocrinologists. The discussion analyzes the physiological stress test of pregnancy on maternal thyroid kinetics including the role of human chorionic gonadotropin and altered iodine clearance. Listeners will review the transition away from r

Recommended